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Abstract Murine studies have linked TGF-b signaling to emphysema, and human genome-wide
association studies (GWAS) studies of lung function and COPD have identified associated regions
near genes in the TGF-b superfamily. However, the functional regulatory mechanisms at these loci
have not been identified. We performed the largest GWAS of emphysema patterns to date,
identifying 10 GWAS loci including an association peak spanning a 200 kb region downstream from
TGFB2. Integrative analysis of publicly available eQTL, DNaseI, and chromatin conformation data
identified a putative functional variant, rs1690789, that may regulate TGFB2 expression in human
fibroblasts. Using chromatin conformation capture, we confirmed that the region containing
rs1690789 contacts the TGFB2 promoter in fibroblasts, and CRISPR/Cas-9 targeted deletion of a ~
100 bp region containing rs1690789 resulted in decreased TGFB2 expression in primary human
lung fibroblasts. These data provide novel mechanistic evidence linking genetic variation affecting
the TGF-b pathway to emphysema in humans.
DOI: https://doi.org/10.7554/eLife.42720.001
Introduction
Emphysema, that is pathologic destruction of lung parenchyma resulting in airspace enlargement, is
one of the major manifestations of chronic obstructive pulmonary disease (COPD). Emphysema
occurs in distinct pathologic patterns, but these patterns are not captured by traditional quantitative
measures of emphysema from lung computed tomography (CT). In order to have more detailed
radiographic measures of emphysema, we developed novel image extraction techniques to quantify
the distinct patterns of emphysema based on the analysis of local lung density
histograms (Mendoza, 2012). These local histogram emphysema (LHE) measures are more predic-
tive of clinical outcomes than standard CT emphysema quantifications (Castaldi et al., 2013), and in
a previous genome-wide association study (GWAS) we identified genome-wide significant
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associations with these distinct LHE patterns (Castaldi et al., 2014). However, the mechanisms by
which these GWAS loci affect emphysema patterns are unknown.
The majority of GWAS-identified loci for genetically complex diseases are located in non-coding
DNA and influence gene regulatory elements (Maurano et al., 2012; Nicolae et al., 2010). Thus, for
the functional characterization of emphysema GWAS loci, it is necessary to localize causal variants in
regulatory elements and identify the gene(s) regulated by that element. Since multiple cell types
contribute to emphysema, large-scale functional annotation projects such as the Genotype-Tissue
Expression Project (GTEx) (GTEx Consortium, 2015) and the Encyclopedia of Regulatory Elements
(ENCODE) (ENCODE Project Consortium, 2012) can be integrated with GWAS signals to identify
candidate regulatory regions, tissues, and cell types of interest for more detailed functional
characterization.
In this study, we hypothesized that human emphysema is influenced by functional genetic variants
that disrupt gene regulatory elements. As a screening approach, we cross-referenced GWAS results
against large compendia of gene regulatory data from tissues and cell types to prioritize emphy-
sema-associated loci for further functional study. This analysis identified rs1690789 as a high-proba-
bility functional variant in the GWAS-identified region near TGFB2. Using chromatin conformation
capture, we confirmed that the region spanning this SNP interacts with the TGFB2 promoter region.
Via CRISPR/Cas-9 targeted deletion, we then demonstrated that a ~ 100 bp segment containing
rs1690789 increases TGFB2 expression in primary human lung fibroblasts, providing novel evidence
that genetic variation affecting TGF-b signaling contributes to the genetic predisposition to
emphysema.
Results
Validation of LHE clinical and genetic associations
In subjects from the COPDGene Study, we have previously demonstrated that LHE measures are
associated with COPD-related phenotypes (Castaldi et al., 2013) and with common genetic variants
at genome-wide significance (Castaldi et al., 2014). To confirm these associations in an independent
cohort and discover new genetic associations, we generated new LHE measures in 1519 subjects
from the ECLIPSE Study, and we replicated the previously observed relationships between LHE pat-
tern and GOLD (Global Initiative for Obstructive Lung Disease) spirometric grade (Figure 1). In the
eLife digest It is well known that smoking is bad for the lungs. Not only can smoking cause lung
cancer, it can also lead to conditions such as emphysema. This is the gradual damage to lung tissue
that occurs when the walls of the tiny air-sacs in the lungs where the blood takes up oxygen, called
the alveoli, weaken and break. Emphysema causes shortness of breath and difficulty pushing air out
of the lungs, and it is part of chronic obstructive pulmonary disease (also known as COPD).
Genetic differences mean that certain people are more likely to develop emphysema than others.
As an example, if someone has genetic mutations that alter the activity of a gene called TGFB2,
their risk of developing emphysema increases. However, the specific genetic mutations that modify
the activity of TGFB2 were previously unknown.
Parker et al. analyzed the genetic sequences of TGFB2 from patients with emphysema and
compared them to those from healthy individuals. This revealed that certain mutations near the
TGFB2 gene were more common in patients with emphysema. Next, Parker et al. showed that, in
healthy lung cells called fibroblasts, the stretch of DNA that was mutated in patients with
emphysema touched the part of TGFB2 that controls when the gene is activated. Deleting that same
stretch of DNA in the fibroblasts meant the cells could no longer activate the TGFB2 gene as
efficiently. Together, these results reveal a genetic difference that increases the risk for emphysema.
COPD affects approximately 175 million people worldwide, causing over three million deaths
each year. The findings of Parker et al. suggest that developing drugs that safely and efficiently
target TGFB2 may be a way to help patients with early signs of emphysema.
DOI: https://doi.org/10.7554/eLife.42720.002
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combined GWAS meta-analysis, we identified 10 independent regions with genome-wide significant
associations to at least one LHE phenotype, six of which had been previously described (Table 1).
One of the four novel associations is rs28929474, the pathogenic GlufiLys substitution in SERPINA1
which is known to be associated with COPD. There was no evidence of systematic inflation in the
QQ-plots of these GWAS (Figure 2). Subject characteristics are shown in Supplementary file 1
Table 1, and complete results by cohort are shown in Supplementary file 1 Table 2.
Since the more severe emphysema patterns (severe centrilobular and panlobular emphysema) are
non-normally distributed, we performed a sensitivity analysis for these top results after performing
inverse normal transformation of the LHE pattern phenotypes (Supplementary file 1 Table 3). In this
analysis, four loci remained genome-wide significant (loci on chromosome 15, 14, 11, and 1), two
loci had p-values<510 7, and four associations to the panlobular and severe centrilobular patterns
had notably lower p-values suggesting that these specific associations are driven by extreme pheno-
type values and should be interpreted with caution.
With regard to the association with the SERPINA1 Z-allele (rs28929474), subjects with known
alpha-1 antitrypsin deficiency had been excluded from our primary analysis. However, when we
examined the imputed genotypes of rs28929474, we identified six individuals in ECLIPSE with
imputed PiZZ genotypes. When we repeated the genetic analysis without these subjects, there was
an increase in association p-value in ECLIPSE (0.003 versus 0.0004, consistent direction of effect),
and the meta-analysis association p-value was 1.6  10 7.
Figure 1. Percentage of each LHE-based emphysema pattern by Global Obstructive Lung Disease (GOLD) stage in ECLIPSE. NE = Non-
emphysematous lung. CL1 = Mild centrilobular. CL2 = Moderate centrilobular. CL3 = Severe centrilobular. PL = Panlobular. PS = Paraseptal. %LAA-
950 = emphysema based on  950 Hounsfield unit threshold.
DOI: https://doi.org/10.7554/eLife.42720.003
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To determine whether these variants were associated with other COPD-related phenotypes, we
queried the LHE GWAS significant associations against the results from two recent large GWAS
studies for FEV1, FEV1/FVC, and COPD status (Shrine et al., 2019; Sakornsakolpat et al., 2019).
Five of the 10 LHE loci (lead variants rs56113850, rs796395, rs17368659, rs145770770, and the
15q25 locus) were associated to at least one of these outcomes at p<0.05 with a consistent direction
of effect (Supplementary file 1 Table 4).
Some loci associated with COPD and related phenotypes have also been associated with smoking
behavior, raising the question of whether the COPD associations at these loci are mediated through
smoking. To determine how many of our associations were also associated to smoking behavior, we
queried our results against the UK Biobank Pheweb server GWAS for prior history of smoking, and
we observed that the only associations that were nominally associated to smoking were the previ-
ously known smoking associations in the 15q25 and 19q13 loci (Supplementary file 1 Table 5).
eQTL colocalization analysis to identify candidate GWAS target genes
and tissue enrichment of LHE GWAS signals
To generate functional hypotheses for emphysema-associated loci and prioritize regions for further
functional study, we integrated our GWAS results with large-scale genome-wide eQTL and cell type
epigenomic data, as shown in Figure 3. To identify emphysema-associated loci that overlap with
eQTL signals from multiple tissues, we cross-referenced our LHE GWAS results against eQTL results
from 44 GTEx tissues and blood eQTLs from COPDGene. Since overlap between GWAS and eQTL
signals can be due to chance, we used a Bayesian colocalization method (Giambartolomei et al.,
2014) to quantify the probability that the local GWAS and eQTL signals were attributable to a
shared causal variant. Four genome-wide significant LHE regions overlapped with eQTL regions with
an estimated >80% probability of a shared causal variant responsible for the GWAS and eQTL asso-
ciations (Table 2).
To identify additional candidate colocalization loci that may be present below the stringent
genome-wide significance threshold, we studied SNPs with a GWAS p<510 5. At this threshold,
the number of GWAS-eQTL overlap loci ranged from 78 (panlobular pattern) to 159 (moderate
Table 1. Genome-wide significant meta-analysis results for local histogram emphysema phenotypes.
LHE pattern Lead SNP Chromosome Position (hg19) EAF Effect allele P value meta Effect meta SE effect meta
Moderate Centrilobular rs56077333 15 78899003 0.67 a 2.2E-13 0.016 2.2E-03
rs17368582 11 102738075 0.14 t 8.1E-12 0.024 3.5E-03
rs56113850 19 41353107 0.59 t 1.5E-09  0.016 2.6E-03
rs796395 1 218681971 0.52 a 6.1E-09 0.013 2.2E-03
rs138641402 4 145445779 0.38 a 3.3E-08 0.014 2.5E-03
Nonemphysematous (Normal Lung) rs138641402 4 145445779 0.38 a 4.2E-08  0.021 3.9E-03
rs7170068 15 78912943 0.78 a 4.8E-12 0.028 4.0E-03
rs17368659 11 102742761 0.86 t 6.3E-11 0.036 5.4E-03
rs28929474* 14 94844947 0.98 t 6.2E-09  0.071 1.2E-02
Panlobular rs11852372 15 78801394 0.35 a 7.1E-12  0.003 5.0E-04
rs76756075* 11 112349844 0.02 t 2.0E-08  0.007 1.2E-03
rs78070126* 11 6574608 0.97 t 2.8E-08 0.006 1.1E-03
rs145770770 2 152487808 0.99 a 3.8E-08  0.015 2.8E-03
Severe Centrilobular rs9788721 15 78802869 0.38 t 3.4E-15  0.005 6.0E-04
rs379123 17 30891814 0.40 t 3.7E-08  0.004 7.0E-04
LHE - local histogram emphysema.
EAF - effect allele frequency in 1000 Genomes CEU population.
*indicates novel association not previously associated in GWAS of COPD or emphysema (rs28929474 was associated to FEV1/FVC in smokers in Li et al.,
2018, during preparation of this manuscript).
DOI: https://doi.org/10.7554/eLife.42720.005
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Figure 2. QQ plots for GWAS meta-analyses of non-transformed LHE phenotypes. (A) Nonemphysematous lung. (B) Mild centrilobular pattern. (C)
Moderate centrilobular. (D) Severe centrilobular. (E) Panlobular.
DOI: https://doi.org/10.7554/eLife.42720.004
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10 genome-wide 
significant loci
Bayesian colocalization with 
multi-tissue eQTLs
4 loci with >80% 
probability of shared 
causal variant.
Select TGFB2 locus, quantify 
causal probability for variants 
near association peak using 
PICS13
7 variants near TGFB2 
each with estimated 
causal probability >5%
Variants predicted to cause 
allele-specific chromatin 
accessibiity?14
rs1690789 identified as 
putative causal variant
Confirm that rs1690789 
region contacts the 
TGFB2 promoter in 
human fibroblasts via 
3C assays
Confirm that the 
rs1690789 region alters 
TGFB2 expression in 
human fibroblasts via 
targeted genetic 
deletions
Figure 3. Overview of integrative analyses to prioritize genome-wide significant emphysema-associated loci for
functional studies.
DOI: https://doi.org/10.7554/eLife.42720.006
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centrilobular pattern), representing between 15% to 33% of the total number of loci with a GWAS
p<510 5. Of these loci, 32 had a > 80% estimated probability of having a shared causal GWAS-
eQTL variant, and we identified the genes whose expression levels are altered by these loci
(Supplementary file 1 Table 6). Full results of this analysis are available at https://cdnm.shinyapps.
io/lhemphysema_eqtlcolocalization/.
To test for tissue-specific enrichment of LHE GWAS signals, we quantified the enrichment of LHE
GWAS regions associated at p<510 5 in DNaseI peak regions from ENCODE and Roadmap cell
types using the Garfield method (Iotchkova et al., 2019). The most commonly enriched cell types
were fibroblasts and fetal lung tissue, as can be seen in the enrichment results for moderate centri-
lobular emphysema (Figure 4). Out of 424 tested cell type annotations, there were 15, 25, and 1 cell
type that exceeded the significance threshold for the moderate centrilobular, nonemphysematous,
and severe centrilobular LHE phenotypes, respectively (Supplementary file 1 Table 7).
Fine mapping identifies a candidate causal variant in the TGFB2 locus
One of the top GWAS-eQTL colocalization signals associated with the moderate centrilobular
emphysema pattern spans a 200 kb region that includes the 3’ UTR of TGFB2 and extends 100 kb
downstream. Multiple SNPs in this region were significantly associated with TGFB2 expression in
human tissues from the GTEx project (Figure 5) with the highest colocalization present with the
eQTL signal in cultured fibroblasts. Given the essential roles of TGF-b signaling and fibroblasts in
lung repair pathways, we selected this locus for further investigation.
To confirm the colocalization results for TGFB2, we performed a separate colocalization analysis
using the same eQTL data but a separate colocalization methodology (He et al., 2013). Sherlock
analysis for the moderate centrilobular GWAS results and GTEx eQTL data from fibroblasts, lung tis-
sue, and whole blood confirmed TGFB2 as a colocalization target for moderate centrilobular emphy-
sema in fibroblasts, and a total of nine colocalizing genes or transcripts were identified at a
p-value<110 4 (Supplementary file 1 Table 8).
The GWAS signal in this region appears to demonstrate two independent peaks of association
spanning a recombination hotspot, with the fibroblast eQTL signal appearing to colocalize with only
one of these signals. We performed conditional genetic association analysis of this region, confirm-
ing the presence of two independent signals (secondary association lead SNP rs3009942
p=4.410 7, Figure 6). To confirm that these are independent signals, we also performed condi-
tional association adjusting for rs3009942, which minimally attenuated the primary association
(rs796395 conditional p-value=3.310 7).
Focusing on the primary association peak which colocalized with the fibroblast eQTL signal, we
estimated the causal probability (i.e. the likelihood that each individual SNP is the causal variant) of
each SNP in this region using the PICS method (Farh et al., 2015), identifying seven variants each
with a > 5% estimated likelihood to be causal (Supplementary file 1 Table 9). We then queried
whether any of these seven SNPs were predicted to alter transcription factor occupancy using the
results of a previously published model developed from ENCODE data (Maurano et al., 2015), iden-
tifying rs1690789 (minor allele frequency of 0.48 in 1000 Genomes EUR population) as the only vari-
ant in this set predicted to have allele-specific effects on transcription factor occupancy.
Table 2. Genomewide significant LHE loci that colocalize with eQTL.
GWAS SNP CHR POS Tissue GENE
Moderate centrilobular rs796395 1 218681971 Fibroblasts TGFB2
rs56077333 15 78899003 Fibroblasts, Testis PSMA4, CHRNA5
Moderate centrilobular, normal rs56113850 19 41353107 Lung, Testis CYP2A6, AKT2
Panlobular rs11852372 15 78801394 Testis CHRNA5
All loci have colocalization probability > 80%, reflecting the estimated probability that the GWAS and eQTL association signals arise from a shared causal
variant.
LHE pattern – local histogram emphysema phenotype used for GWAS.
SNP - lead GWAS variant in locus.
Tissue - tissue of origin for gene expression data in eQTL analysis.
Gene – eQTL targeted gene in specified GTEx tissue.
DOI: https://doi.org/10.7554/eLife.42720.007
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Analysis of DNaseI accessibility near rs1690789 across various cell
types in publicly available data
Using the ENCODE uniformly processed DNaseI hypersensitivity dataset of 125 cell types, we
observed that rs1690789 lies within a DNaseI hypersensitivity peak identified in 13 cell types (Fig-
ure 5, Panel C). Eight of these 13 cell types were fibroblasts, although this peak was not universally
detected in all fibroblast DNaseI experiments, suggesting that this may be a context-specific regula-
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Figure 4. Cell type and tissue enrichment for moderate centribloular emphysema GWAS signals. Using Garfield (Iotchkova et al., 2019) for enrichment
analysis, we tested the enrichment of moderate centrilobular GWAS loci (harboring associations a p<510 5) in DNaseI peaks from 424 cell lines and
cell types in ENCODE and Roadmap. Significant enrichments were observed in fetal lung, fetal stomach, and multiple fibroblast cell types. These
significant enrichments are denoted by colored dots located just inside the boundary of the circle of cell types.
DOI: https://doi.org/10.7554/eLife.42720.008
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Figure 5. The locus zoom plot of GWAS p-values suggests two independent associations (Panel A), and the GWAS signal colocalizes with an eQTL
signal in fibroblasts from GTEx (Panel B). rs1690789 is located at one of these GWAS association peaks and lies within a context-specific DNaseI peak
(Panel C). GM12878, H1hESC, and K562 cell lines are shown for reference, and the remaining cell types are those with DNaseI peaks that overlap
rs1690789. Raw DNaseI data from only one experimental replicate are shown. GM12878 = lymphblastoid cell line. H1hESC = human embryonic stem
cell. K562 = leukemia cell line. AG0449-AG10803 refer to fibroblasts from different subjects and sampling sites. HGF = gingival fibroblasts.
HMVECLLy = lung derived microvascular endothelial cells. HPdLF - Periodontal ligament fibroblasts. HRPEpiC – retinal pigment epithelial cells. HSMM
– skeletal muscle myoblasts. NHDF – dermal fibroblasts. NHLF – lung fibroblasts.
DOI: https://doi.org/10.7554/eLife.42720.009
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Chromatin interaction between GWAS peak regions and the TGFB2
promoter
Since rs1690789 is located ~200 kb from the transcription start site of TGFB2, we hypothesized that
this region may regulate TGFB2 expression via a long-range chromatin interaction. Using publicly
available 4C-Seq chromatin conformation data from IMR90 human lung fibroblasts (Rao et al.,
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Figure 6. Secondary association for moderate centrilobular emphysema at the TGFB2 locus. Results from genetic association meta-analysis conditioned
on the lead SNP (rs796395) at this region.
DOI: https://doi.org/10.7554/eLife.42720.010
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downstream regions around TGFB2 (Figure 7A), suggesting that this region is a hotspot of chromo-
somal interaction.
To confirm whether rs1690789 region indeed interacts with the promoter of TGFB2 in lung fibro-
blasts, we performed chromatin conformation capture (3C) experiments in human lung fibroblasts
(IMR90). Using the TGFB2 promoter region as the anchor region, we detected interaction between
Figure 7. Publicly available chromatin conformation capture (4C) results in IMR90 cells show multiple peaks of interaction for the 10 kb region
containing the context-specific regulatory element around rs1690789 (Panel A – blue spikes in top figure indicate regions of high interaction frequency
and light blue curved lines in lower figure indicate chromosomal interactions with the 10 kb region containing rs1690789). Newly generated 3C assays in
IMR90 fibroblasts verify the interaction between the region containing rs1690789 and TGFB2 promoter (Panel B). Primer sequences are listed in
Supplementary file 1 Table 10.
DOI: https://doi.org/10.7554/eLife.42720.011
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the rs1690789-containing region and the TGFB2 promoter in lung fibroblasts (Figure 7B), suggest-
ing long range regulation of TGFB2 by the region containing rs1690789.
Deletion of the rs1690789 region alters TGFB2 expression in lung
fibroblasts
To determine whether the DNA region near rs1690789 has regulatory effects on the expression of
TGFB2 in human lung fibroblasts in the endogenous genomic context, we generated CRISPR/Cas-9
constructs containing gRNA pairs targeting the ~100 bp region spanning rs1690789 (Figure 8A) to
generate genomic deletions in normal primary human lung fibroblasts. With sufficient deletion effi-
ciency of the region spanning rs1690789, we detected reduced expression of TGFB2 (Figure 8B and
C, Supplementary file 1 Table 11), indicating that this distal genomic region has regulatory effects
on the expression of TGFB2 in normal primary human lung fibroblasts.
Figure 8. Regional knockout of rs1690789 in primary human lung fibroblasts using CRISPR/Cas9 editing. Three pairs of sgRNAs were applied to delete
a DNA region of ~100 bp spanning rs1690789 (A). The expression of TGFB2 is downregulated in rs1690789 knockout lung fibroblast cells with qPCR
quantification, n = 4 (B). The editing efficiency is examined to confirm the effect of CRISPR/Cas9 regional knockout, n = 4 (C). *p<0.05 compared to
control by unpaired t test.
DOI: https://doi.org/10.7554/eLife.42720.012
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Discussion
Previous GWAS studies have demonstrated that common genetic variation contributes to
emphysema (Cho et al., 2015), likely through the perturbation of gene regulatory
mechanisms (Castaldi et al., 2014). In order to identify putative causal variants and regulatory mech-
anisms for these loci, we used a screening approach that leverages large compendia of gene regula-
tory information in the GTEx and ENCODE projects. Using Bayesian colocalization, we identified 32
emphysema-associated loci at p<510 5 where it is likely that colocalized GWAS and eQTL signals
arise from the same causal variant. It should be noted that these are putative and not confirmed dis-
ease variants due to our use of a relaxed GWAS significance threshold and the inherent complexities
of colocalization, which continues to be an area of active methodological development. For the
genome-wide significant locus near TGFB2, multiple sources of publicly available and newly gener-
ated experimental data link a functional variant, rs1690789, to TGFB2 expression in fibroblasts.
These data suggest that naturally occurring genetic variability in TGF-b signaling plays a causal role
in the development of emphysema.
The TGF-b family of proteins constitutes a set of highly conserved signaling pathways that play a
key role in human development and many other cellular functions (Huminiecki et al., 2009; Mas-
sagué, 2012). With respect to the lung, TGF-b family proteins participate in normal lung develop-
ment and are dysregulated in COPD, emphysema, asthma, and pulmonary
fibrosis (Verhamme et al., 2015; Morris et al., 2003; Thomas et al., 2016). Genetic variants near
TGF-b superfamily members TGFB2 (Castaldi et al., 2014; Cho et al., 2014),
ACVR1B (Boueiz et al., 2019), LTBP4 (Wain et al., 2017), and BMP6 (Loth et al., 2014) have been
identified in GWAS for lung function and COPD, but prior to this study the region near ACVR1B was
the only one linked to a gene in the TGF-b pathway through functional studies (Boueiz et al., 2019).
Our findings demonstrate that the emphysema-associated variant rs1690789 is located in an active
gene regulatory region in human lung fibroblasts that interacts with the promoter region of TGFB2
and regulates TGFB2 expression.
These analyses highlight the genetic and gene regulatory complexity of this region. Conditional
association analyses identified two independent associations with moderate centrilobular emphy-
sema near TGFB2, and both associations are in linkage equilibrium (i.e. low linkage disequilibrium)
with the lead variant identified in a previous GWAS of severe COPD (Cho et al., 2014). In addition,
the region containing rs1690789 has multiple interactions with other DNA regions, including the
TGFB2 promoter and other downstream regions, indicating that this is a region of active chromatin
interaction in human lung fibroblasts.
While our analyses provide evidence that the emphysema-associated GWAS region downstream
from TGFB2 interacts with the promoter of TGFB2 and regulates the expression of TGFB2 in human
primary lung fibroblasts, many important questions remain about the function of the emphysema-
associated locus near TGFB2. First, the rs1690789 variant appears to be an eQTL for expression of
TGFB2 in fibroblasts, but it is also strongly associated with TGFB2 expression in thyroid tissue in
GTEx with an opposite direction of effect, suggesting complex and possibly context-dependent
activity of this region. This is further supported by the observation that rs1690789 lies within a DNa-
seI peak in some but not all fibroblasts in the ENCODE and Roadmap projects, suggesting that the
regulatory element in this region may be active only in certain fibroblast subsets, under certain con-
ditions, or that the regulatory activity of this region is influenced by common (but unmeasured)
genetic variation in these cells. Additional investigations are warranted to examine the context-spe-
cific function of this region. Second, our studies do not explain the function of the secondary associa-
tion signal in this region, and it is also possible that both association regions may have functional
effects in other cell types that contribute to COPD susceptibility. Third, it is possible that even within
a single, statistically independent association peak, there may be multiple functional variants in tight
linkage disequilibrium that contribute to the emphysema-related effects of this region. Future func-
tional screening studies of this region can address this question. Finally, gene-level functional studies
will be required to characterize the functional consequences of increased and decreased TGFB2
expression on lung fibroblast function.
In summary, integrative GWAS-eQTL analysis of emphysema patterns identified 32 candidate loci
with strong evidence of harboring gene regulatory variants responsible for the GWAS signal, includ-
ing a locus near TGFB2. Functional investigation of the associated region near TGFB2 confirmed the
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presence of a functional variant, rs1690789, that likely contributes to the genetic predisposition to
emphysema by regulating TGFB2 expression in fibroblasts. This region has multiple independent
association signals and an extensive pattern of chromosomal interaction, indicating that additional
investigations are required to fully characterize the gene regulatory activity at this locus. In addition
to the association near TGFB2, we identified dozens of other high confidence regions in our colocali-
zation analysis, indicating additional functional variants that could be identified by high-throughput





The Genetic Epidemiology of COPD Study (COPDGene, NCT00608764, www.copdgene.org) is an
ongoing multicenter, longitudinal study designed to investigate the genetic and epidemiologic char-
acteristics of COPD. The protocols for subject recruitment and data collection for the COPDGene
study have been previously described (Regan et al., 2010). At baseline, COPDGene enrolled 10,192
Non-Hispanic White (NHW) and African-American (AA) subjects at 21 centers across the United
States between the ages of 45 and 80 years with a minimum of 10 pack-years smoking history. Sub-
jects represented the full spectrum of disease severity as defined by the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) spirometric grading system. In addition to completing detailed
questionnaires, pre- and post-bronchodilator spirometry, and volumetric computed tomography of
the chest, participants provided whole blood for DNA genotyping.
Genotyping was performed by Illumina (San Diego, CA) on the HumanOmniExpress array. Sub-
jects were excluded for missingness, heterozygosity, chromosomal aberrations, gender check, popu-
lation outliers, and cryptic relatedness. Genotyping at the Z and S alleles was performed in all
subjects. Subjects known or found to have alpha-1 antitrypsin deficiency were excluded. Markers
were excluded based on missingness, Hardy- Weinberg P-values, and low minor allele frequency.
Imputation on the COPDGene cohorts was performed using MaCH and minimac (version 2012-10-
09) (Li et al., 2010; Howie et al., 2012). Reference panels for the non- Hispanic whites and African-
Americans were the 1000 Genomes3 Phase I v3 European (EUR) and cosmopolitan reference panels,
respectively.
ECLIPSE
The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Study (ECLIPSE;
SCO104960, NCT00292552, www.eclipse-copd.com) is a longitudinal study with three-year follow-
up data available for 2501 smoking subjects (2164 subjects with COPD and 337 smoking controls).
The detailed study protocol and inclusion criteria have been previously published (Vestbo et al.,
2008). For this analysis, 1519 subjects with COPD (defined as GOLD spirometric stages 2–4) and
available CT scans were analyzed. COPD was defined by FEV1 <80% of predicted and FEV1/
FVC < 0.7.
Genotyping was performed using the Illumina HumanHap 550 V3 (Illumina, San Diego, CA). Sub-
jects and markers with a call rate of <95% were excluded. Subjects with alpha-1 antitrypsin defi-
ciency based on serum protein levels were excluded from this analysis. Population stratification and
genotype imputation was performed using the same procedures and software as described above
for COPDGene. GWAS models were adjusted for age, gender, pack-years of smoking history, and
genetic ancestry via principal components.
Common variant genetic association analysis of LHE measures
We performed GWAS analyses of the 5 LHE measurements separately in the three cohorts (COPDG-
ene NHW, COPDGene AAs, and ECLIPSE, total N = 11,282 subjects, 18,383,174 SNPs imputed to
the 1000 Genomes reference panel, version 3, hg19). Analysis was limited to imputed SNPs with an
imputation r2 >0.3. Imputed genotypes were analyzed using the –dosage command in PLINK v1.9
(Chang et al., 2015), though for SNPs with genotyped data the observed genotypes were used.
GWAS models were adjusted for age, gender, pack-years of smoking history, and genetic ancestry
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via principal components (Price et al., 2006). Results were meta-analyzed using the
METAL (Willer et al., 2010) program using fixed effects meta-analysis with inverse variance weight-
ing using SNP effect sizes and standard errors. We analyzed SNPs with a MAF >1%, and we meta-
analyzed SNPs with results in at least two of the three cohorts.
CT scan acquisition and generation of LHE measures
The generation of LHE measures in COPDGene has been previously described (Castaldi et al.,
2013). For the current studies, additional LHE measures were generated in ECLIPSE CT scans using
the same method.
Clinical associations of LHE measures in ECLIPSE
LHE measurements have been previously associated with key COPD-related measures (e.g. spirome-
try, MMRC) (Castaldi et al., 2013). To test if this relationship was consistent in the measurements
generated in ECLIPSE, we visualized the median percentage of each emphysema pattern by GOLD
stage.
GWAS lookups of LHE significant variants in GWAS of FEV1, FEV1/FVC,
COPD, and smoking behavior
For the 14 lead SNPs associated with one or more of the LHE phenotypes at genome-wide signifi-
cance, we queried other COPD-related GWAS for these variants or variants in linkage disequilibrium
with these variants (r2 >0.8 in the 1000 Genomes EUR reference panel). The queried GWAS studies
were published studies of FEV1 and FEV1/FVC (Shrine et al., 2019), COPD
status (Sakornsakolpat et al., 2019), or history of smoking. The smoking GWAS results were
obtained from the UK Biobank Pheweb server (http://pheweb.sph.umich.edu:5000/) on July 7, 2019
for the phenotype ‘20116_1: Smoking status: Previous.’
eQTL data and colocalization analysis
For colocalization and cell type enrichment analyses, GWAS SNPs significant at p<510 5 were con-
sidered. GTEx version six full results for 44 tissues were downloaded from the GTEx portal (https://
www.gtexportal.org/home/datasets), and eQTLs were calculated from blood RNAseq data in 385
NHW subjects from the COPDGene study using the same methods used in the GTEx Study v6 analy-
sis. Details on the generation of COPDGene RNAseq data have been previously
described (Parker et al., 2017). GWAS-eQTL integrative analysis was performed according to the
approach previously described in Castaldi et al. (2015). Briefly, for each set of eQTL results, SNPs
with a significant cis eQTL association at a 10% FDR threshold were extracted from each of the five
sets of LHE GWAS results. Q-values were calculated for each subset of GWAS SNPs separately using
the q-value package (Storey et al., 2019), and SNPs demonstrating both significant eQTL and
GWAS associations were retained for subsequent analysis (i.e. eQTL-GWAS SNPs). Within each set
of eQTL-GWAS SNPs, association regions for colocalization were defined by selecting all SNPs
within 250 kilobases (kb) of each independent GWAS association. Colocalization of the GWAS and
eQTL signals in these regions was calculated using the Bayesian colocalization method implemented
in the R package coloc (Giambartolomei et al., 2014) using the default settings for the prior proba-
bility of a SNP being associated to target gene expression, the GWAS phenotype, and both meas-
ures (prior probability 1  10 4, 1  10 4, and 1  10 5, respectively).
To confirm the colocalization results for TGFB2, colocalization was also performed for the GWAS
results for moderate centrilobular emphysema using the Sherlock method (He et al., 2013). This
analysis was performed using all the moderate centrilobular GWAS results referenced against three
GTEx v6 eQTL datasets (transformed fibroblasts, lung, and whole blood). The following parameter
settings were used: cis eQTL significance threshold p<0.001, trans eQTL significance threshold
p<110 5.
Causal SNP estimation with PICS
To narrow the list of putative causal variants for the primary association near TGFB2, we used the
probabilistic inference of causal SNPs algorithm (PICS) (Farh et al., 2015) which infers per SNP
causal probabilities from the strength of association of the lead SNP and linkage disequilibrium
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information from 1000 Genomes reference populations. The EUR reference population was used for
this analysis, which was conducted via the PICS web interface (https://pubs.broadinstitute.org/pubs/
finemapping/pics.php).
Identification of variants predicted to effect transcription factor
occupancy
For SNPs with a PICS causal probability of 5% or greater, we queried these SNPs against their Con-
textual Analysis of Transcription Factor Occupancy (CATO) model predictions (Maurano et al.,
2015), which was trained on deep DNaseI sequencing data from the Roadmap project to predict
per-SNP effects on transcription factor occupancy based on the predicted effects of each SNP on
the binding energy of overlapping TF motifs and a number of factors related to local genomic
sequence content. SNPs exceeding a CATO score of 0.1 were considered likely to alter TF
occupancy.
Cell type and cell line GWAS enrichment analysis with garfield
To determine whether LHE GWAS association were enriched in gene regulatory annotations from
ENCODE and Roadmap Epigenomics data, we performed enrichment analysis for the LHE pheno-
types with genome-wide significant results using the Garfield program and its pre-processed epige-
nomic annotations (Iotchkova et al., 2019). The GWAS significance threshold was set at p<510 5,
and the default parameters were used for LD pruning (r2 >0.1), LD proxy threshold (r2 >0.8), minor
allele frequency binning (five bins), LD tag binning (five bins), and TSS distance binning (five bins).
The significance threshold was set at p<0.0001 corresponding to Bonferroni adjustment for the
effective number of independent annotations.
Overlap of rs1690789 with cell-specific DNaseI peaks
Imputed DNaseI hypersensitivity peaks from Roadmap Epigenomics cell types or cell
lines (Ernst and Kellis, 2015) were downloaded from http://egg2.wustl.edu/roadmap/data/byFile-
Type/peaks/consolidatedImputed/narrowPeak/. The overlap of rs1690789 with DNaseI peaks and
enhancer marks was identified using the GoShifter program (Trynka et al., 2015), and the raw DNa-
seI data for these cell types was visualized using the UCSC Genome browser.
Cell culture
IMR-90 fibroblasts were purchased from ATCC and cultured in Eagle’s Minimal Essential Medium
(EMEM, #12–611F, Lonza) supplemented with 10% fetal bovine serum, penicillin and streptomycin.
The cells tested negative for mycoplasma by MycoAlert Detection Kit (#LT07-418, Lonza). Primary
human lung fibroblast cells were isolated from the lung tissue of healthy individuals (Marsico Lung
Institute, University of North Carolina at Chapel Hill, North Carolina) as previously
described (Fulcher et al., 2005). Briefly, lung tissue samples were cut into small pieces and seeded
onto culture dishes supplemented with DMEM/F12 medium, 10% fetal bovine serum, penicillin,
streptomycin, amphotericin B and gentamicin. Amphotericin B and gentamicin were removed from
the medium after the cells were passaged. The primary human lung fibroblasts were passaged twice
and grown to 90% confluence prior to subsequent experiments. Human lung tissue was obtained
under protocol #03–1396 approved by the University of North Carolina at Chapel Hill Biomedical
Institutional Review Board.
4C data in IMR90 cell lines
4C chromosome conformation interaction results from the paper by Rao et al. (2014) were queried
from the Yue Lab public website (http://promoter.bx.psu.edu/) using the following search parame-
ters: Species = human, Assembly = hg19, Tissue = IMR90, Type = Lieberman VC-norm, Resolu-
tion = 10 kb, SNP = rs1690789, Extended Region = 500 kb.
Chromatin conformation capture assay (3C)-PCR
Human lung fibroblasts IMR90 cells were cultured to 80% confluency then cross-linked and lysed fol-
lowed by digestion with BglII overnight. DNA fragments were then ligated with T4 ligase (New Eng-
land Biolabs, #M0202L) for 6 hr at 16˚C. After purification, 3C templates were used in PCR detection
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with unidirectional primers to indicate specific chromatin interaction by comparing relative band
intensity from targeted regions against negative and positive control regions with three technical
replicates (i.e. same 3C templates, multiple PCR repeats). Primer sequences used for 3C-PCR are
listed in Supplementary file 1 Table 10. Detailed description of our methods has been published
previously (Zhou et al., 2012).
CRISPR/Cas9 rs1690789 knockout
To generate the rs1690789 CRISPR/Cas9 regional knockout primary human lung fibroblast cells, two
guide RNAs (u1 forward: 5’- GATACTCCAGTACATTGAGAAGG-3’; u2 forward: 5’-TGGAGTATCA
TTTCAGTGTTAGG-3’) located upstream from the SNP and two guide RNAs (d1 forward: 5’-CAG-
CAGCGAGTTTGGCACTCAGG-3’; d2 forward: 5’-TGTCTCATTGCACACTCATGGGG-3’) located
downstream from the SNP were cloned into pSpCas9 (BB) 2A-Puro (PX459) V2.0 vectors (Addgene
plasmids #62988), individually. Plasmids were verified by DNA sequencing. FuGENEHD was applied
to transfect three pairs of gRNA plasmids (u1 and d1, u1 and d2, u2 and d2) into primary normal
human lung fibroblast (NHLF) cells according to the manufacturer’s instructions. PX459 empty vec-
tors were transfected as control. Forty-eight hours after transfection, cells were selected with 1.2 mg/
mL puromycin. After 2–3 weeks of recovery and expansion, cells were collected for DNA, RNA
extraction and qPCR. Four biological replicates were performed (i.e. same donor, four different
transfections).
Assessment of CRISPR/Cas9 editing efficiency
DNA samples from human lung fibroblast cells were extracted using QuickExtract DNA Extraction
solution (#QE0905T, Lucigen, WI) following manufacturer’s instructions. SYBRGreen dye-based quan-
titative RT-PCR was performed using the same equipment system and analysis method mentioned
above, with the following primers to assess editing efficiency (forward: 5’- GTTACCGATGCTTAAA
TGCCAC-3’; reverse: 5’- AGAATATCCCCATGAGTGTGC-3’). The control was cells transfected with
PX459 empty vector.
Gene expression measurements by RT-PCR
Human lung fibroblast cell RNA was extracted using RNeasy Mini Kit (#74106, Qiagen, MD), and
reverse transcription was performed by using High-Capacity cDNA Reverse Transcription Kit
(#4374966, Applied Biosystems, MA). Quantitative RT-PCR was performed on QuantStudio 12K Flex
Real-Time PCR System (Applied Biosystems) with gene-specific TaqMan probes (Hs.PT.58.24824921)
from IDT (Integrated DNA technologies, IA) for detecting TGFB2 expression. Relative gene expres-
sion level was calculated based on the standard 2 DDCT method, using GAPDH as a reference gene.
For both the TGFB2 expression and editing efficiency tests, qPCR values were normalized against
the mean qPCR value for the control cells for each experiment. Comparisons were performed using
unpaired t-tests.
Study approval
Written, informed consent was obtained for all participants, and all study and consent forms were
approved by the institutional review boards of the participating institutions.
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